Trial · NCT07889921
TECAR and FES for Hand Function in Post-Stroke Spasticity
NCT07889921, Not applicable, Completed, October 6 University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. TECAR and FES for Hand Function in Post-Stroke Spasticity. Trials, record NCT07889921. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889921
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- TECAR and FES for Hand Function in Post-Stroke Spasticity
- NCT number
- NCT07889921
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 50 participants, actual
- Lead sponsor
- October 6 University
- Conditions
- Neuro: Cerebrovascular Accident
- Interventions
- FES therapy, TECAR therapy and FES
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Modified Ashworth Scale | one month | a 6-point clinical tool used to measure increased muscle tone (hypertonia) and resistance to passive movement in patients with central nervous system conditions. Scoring: grade 0 (normal), grade 1 and 1+ (mild spasticity), grade 2 and 3 (moderate spasticity), grade 4 (severe spasticity) |
| Primary | Action Research Arm Test | one month | a 19-item observational measure used by clinicians to evaluate upper-extremity coordination, dexterity, and functional performance in patients with neurological conditions such as stroke, traumatic brain injury (TBI), or multiple sclerosis. A 4-point rating system is used to evaluate task performance, with 0 representing no movement and 3 representing normal movement |
| Secondary | The upper extremity Fugl-Meyer Assessment | one month | A 3-point ordinal scale, with 0 representing "cannot perform," 1 representing "performs partially," and 2 representing "performs fully," is used to rate scale items based on the ability to complete them. 226 is the maximum possible score on the scale. |
| Secondary | Functional Independence Measure (FIM) self-care component | one month | Self-care independence, sphincter control, transfers, mobility, communication, and social cognition are all evaluated. The degree of assistance needed determines the functional status, which ranges from entire assistance to complete independence. Higher scores indicate greater independence. The total score falls between 18 and 126. |
| Secondary | Surface electromyography (sEMG) | one month | a safe, non-invasive technique that records the electrical activity of skeletal muscles using electrodes placed directly on the skin. Measurements: evaluate activation of extensor carpi radialis (ECR) and extensor digitorum communis (EDC). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889921
GET https://conductscience.org/api/trials/v1/NCT07889921/registered